Hot Features
프리미엄
Lexeo Therapeutics Inc (LXEO)
NASDAQ
실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. 더 보기
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.59 | -23.8738738739 | 6.66 | 6.71 | 4.78 | 256668 | 5.74808882 | CS |
| 4 | -0.84 | -14.2131979695 | 5.91 | 7.66 | 4.78 | 217039 | 6.37272002 | CS |
| 12 | -4.77 | -48.4756097561 | 9.84 | 11.72 | 4.78 | 370995 | 7.35963751 | CS |
| 26 | -7.44 | -59.4724220624 | 12.51 | 13.63 | 4.78 | 335431 | 9.04763255 | CS |
| 52 | -10.69 | -67.8299492386 | 15.76 | 22.33 | 4.78 | 255538 | 11.09842218 | CS |
| 156 | -4.43 | -46.6315789474 | 9.5 | 22.33 | 4.78 | 235705 | 11.22643994 | CS |
| 260 | -4.43 | -46.6315789474 | 9.5 | 22.33 | 4.78 | 235705 | 11.22643994 | CS |
